Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
January 20, 2020Journal of Clinical MedicineOpen Access

Serum Exosomal MicroRNA, miR-10b-5p, as a Potential Diagnostic Biomarker for Early-Stage Hepatocellular Carcinoma

View Full Paper
Ask AI
Bookmark
Share

Authors

HCHyo Jung ChoDongduk Women's UniversityJEJung Woo EunUniversity of SeoulGBGeum Ok BaekAjou University

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Cho et al. (2020) studied this question.

synapsesocial.com/papers/6a710e9bfebe604dd709c8adhttps://doi.org/10.3390/jcm9010281
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Expression of Serum Exosomal MicroRNA-21 in Human Hepatocellular Carcinoma2014 · 291 citations
  2. 2Tumor suppressor miR-215 counteracts hypoxia-induced colon cancer stem cell activity2019 · 57 citations
  3. 3Serum exosomal microRNAs as novel biomarkers for hepatocellular carcinoma2015 · 434 citations
  4. 4The GALAD scoring algorithm based on AFP, AFP-L3, and DCP significantly improves detection of BCLC early stage hepatocellular carcinoma2016 · 122 citations
  5. 5miRNA profiling in metastatic renal cell carcinoma reveals a tumour-suppressor effect for miR-2152011 · 163 citations